top of page

STUDY SHOWS HIGH PREVALENCE OF BUPRENORPHINE 'SPIKING' IN URINE SCREENINGS FOR OUD PATIENTS

JAMA [3/28] | More than 7% of urine samples collected in a recent cross-sectional study [...] showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence by opioid use disorder (OUD) patients.Cont.

1 view0 comments

Recent Posts

See All

SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.

bottom of page